Early Toxicity Testing 2016 Market Share,Size,Trends and Forecast to 2022 Market Research Report

WiseGuyReports.com adds“Early Toxicity Testing 2016 Market Share,Size,Trends and Forecast to 2022 Market Research Report”reports to its database.

COMPLETE REPORT DETAILS @ https://www.wiseguyreports.com/reports/world-blood-testing-technologies-market-opportunities-and-forecasts-2014-2022

Testing of blood is one of the oldest and most widely used techniques to rule out the presence of any disease. Blood tests are used to assure the biochemical and physiological well-being of the humans. They are also used to confirm the proper functioning of vital organs such as liver, kidney and thyroid and to understand the effectiveness of given therapeutics. The technological innovations along with consistent demand for better blood testing technologies have intensified the global competition. The market is growing owing to the burgeoning demand for point-of-care and minimally invasive testing devices.

The major factors fuelling the global blood testing technologies market growth are high incidence of lifestyle diseases, cancer, infectious diseases and genetic disorders. Large pool of old age population along with increased public and private spending on diagnostics and research are other significant factors leading to market growth. Rising number of diagnostic centers, hospitals and emergence of home care diagnostics have opened lucrative avenues in the blood testing market. However, lack of awareness, reluctance to adopt newer technologies and unavailability of skilled labor are likely to restrain the market growth.

For more information or any query mail at sales@wiseguyreports.com

     

The global blood testing technologies market is segmented on the basis of type, technology, end user and geography. On the basis of type, the market is segmented into Complete Blood Count (CBC), Basic Metabolic Panel (BMP) such as blood glucose test, electrolyte test and kidney test; blood enzyme tests such as Troponin and Creatine Kinase; tests to assess heart disease risk such as lipoprotein panel and cholesterol test and blood clotting tests; and others such as Erythrocyte Sedimentation Rate (ESR). On the basis of technology, the market is segmented into Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescent immunoassay (CLIA), Radioimmunoprecipitation assay (RIPA), Nucleic Acid Amplification Test (NAAT), Polymerase Chain Reaction (PCR), Transcription-mediated Amplification (TMA), Enzyme Immunoassay (EIA), Immunofluorescence Assay (IFA), Next Generation Sequencing (NGS) and Western Blot Test. The market is segmented on the basis of end user into hospitals and clinics, diagnostic centers and homes. Geographically, the market is segmented across four regions viz., North America, Europe, Asia-Pacific and LAMEA.

Few strategies adopted by industrial players are collaborations and acquisitions. For instance Roche Diagnostics, in Dec 2014, acquired Ariosa Diagnostics, to enter into non-invasive prenatal test (NIPT) and cell-free DNA testing services markets. Ariosa’s proprietary Harmony Prenatal Test is a blood test that measures fetal cfDNA found in maternal blood. Recently, Philips has entered into collaboration agreement with Janssen Pharmaceutica N.V., to develop a handheld blood test intended to be used in neuropsychiatric care. The companies profiled in the report include Abbott Laboratories, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Siemens AG., Thermo Fisher Scientific Inc., Becton Dickinson and Company, bioMérieux SA, Koninklijke Philips N.V., Alere Inc. and Medtronic plc.

KEY MARKET BENEFITS

Comprehensive analysis of factors that drive and restrict the growth of the global blood testing technologies market is provided
The market estimations are made in the report by conducting high-end analysis of the key market segments for the period of 2014-2020, which would enable the stakeholders to capitalize on prevailing Market - Opportunities
An in-depth analysis of key segments of the market demonstrates the types of blood testing equipment along with the technologies and end-users in blood testing market
SWOT analysis enables to study the internal environment of the leading companies for strategy formulation
Region-wise blood testing technologies market conditions are comprehensively analyzed in this report 

REQUEST FOR TABLE OF CONTENTS @ https://www.wiseguyreports.com/request-toc/world-blood-testing-technologies-market-opportunities-and-forecasts-2014-2022

KEY MARKET SEGMENT: 

The global blood testing technologies market is segmented below: 

Global Blood Testing Technologies Market - By Type

Complete Blood Count (CBC)
Basic Metabolic Panel (BMP)
Blood Glucose Test
Electrolyte Test
Kidney Test
Blood Enzyme Tests
Troponin
Creatine Kinase
Tests To Assess Heart Disease Risk
Lipoprotein Panel and Cholesterol Test
Blood Clotting Tests
Others
Erythrocyte Sedimentation Rate (ESR) 

Global Blood Testing Technologies Market - By Technology

Enzyme-Linked Immunosorbent Assay (ELISA)
Chemiluminescent immunoassay (CLIA)
Radioimmunoprecipitation assay (RIPA)
Nucleic Acid Amplification Test (NAAT)
Polymerase Chain Reaction (PCR)
Transcription-Mediated Amplification (TMA)
Enzyme Immunoassay (EIA)
Immunofluorescence Assay (IFA)
Next Generation Sequencing (NGS)
Western Blot Test 

Global Blood Testing Technologies Market - By End User

Hospitals and Clinics
Diagnostic Centers
Homes 

Global Blood Testing Technologies Market - By Geography

North America
Europe
Asia-Pacific
LAMEA

RESEARCH METHODOLOGY

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
 

• Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
• Technologically sophisticated and reliable insights through well audited and veracious research methodology
• Sovereign research proceeds that present a tangible depiction of marketplace

CONTINUE…….

PRE-BOOK REPORT @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=513095

For more information or any query mail at sales@wiseguyreports.com

Contact Us:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)